(Source: Teva Pharmaceuticals USA Inc) Teva Launches Generic Abilify® Tablets in the United States JERUSALEM--(BUSINESS WIRE)--Apr. 28, 2015-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced the launch of the generic equivalent to Abilify® (aripiprazole) Tablets, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, in the United States. Aripiprazole tablets, an atypical antipsychotic medication, are approved for the treatment of schizophrenia and for the acute treatment of manic and mixed episodes associated with bipolar I disorder. "Our commitment at Teva is to make affordable, high-quality generic medicines available to millions of patients every day. We are pleased to launch...
↧
